Guardant Health (GH) Acquisitions (2019)

Guardant Health (GH) posted Acquisitions of -$2.4 million for Q3 2019.

Guardant Health (GH) Acquisitions (2019) Analysis & Trends

Guardant Health has reported Acquisitions for 1 years, with the latest figure at -$2.4 million in Q3 2019.

  • Quarterly Acquisitions changed N/A year-over-year to -$2.4 million in Q3 2019, while the trailing twelve-month figure through Dec 2020 was -$2.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $59.0 million, changed N/A from the prior year.
  • Acquisitions was little changed at -$2.4 million in Q3 2019 per GH's latest filing.
  • Over five years, Acquisitions peaked at -$2.4 million in Q3 2019 and troughed at -$2.4 million in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn 163.00 Mn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn 2.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -
10 Guardant Health 21.59 Bn 20.53 Bn 219.03 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 -2.44 Mn